Eye tests could spot silent vision damage in lupus patients

NCT ID NCT07679776

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: The First Affiliated Hospital of Anhui Medical University Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether people with systemic lupus erythematosus (SLE) show early signs of retinal damage before they notice any vision problems. Researchers will use advanced eye imaging and vision tests to compare lupus patients with healthy volunteers. The goal is to find markers that could help doctors detect and treat eye involvement earlier, potentially preserving vision and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify early warning signs of eye damage in lupus patients, allowing doctors to intervene sooner and potentially prevent vision loss.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to direct improvements in care, and the findings might not apply to all lupus patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) VISUAL FUNCTION

Contacts and locations

Locations

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.